Drug Index

Vitamin K

Synonyms :

Phytomenadione, Phytonadine, Phytonadione, Vitamin K1

Mechanism :

Vitamin K compounds are fat soluble naphthoquinones. Vitamin K1 and vitamin K2 occur in a variety of natural materials and are synthesized by certain bacteria in the gastrointestinal tract; however, commercially prepared phytonadione is synthetically produced. Phytonadione possesses essentially the same type and degree of activity as naturally occurring vitamin K1.

Indication :

  • Vitamin K deficiency prophylaxis
  • Hemorrhagic disease of newborn
  • Malabsorption syndrome
  • Cystic fibrosis
  • Biliary atresia
  • Hepatic failure
  • Antidote to warfarin

Contraindications :

Hypersensitivity to vitamin K.

Dosing :


0-6 months: 2 mcg/day

6-12 months: 2.5 mcg/day

1-3 years: 30 mcg/day

4-8 years: 55 mcg/day

9-13 years: 60 mcg/day

14-18 years: 75 mcg/day

1 mg can be given IM to healthy neonates >36 weeks gestation, at birth or shortly after.

For deficiency of Vitamin K in infants and children:

2.5 to 5 mg orally once every 24 hours. Alternatively, 1 to 2 mg IV, IM or subcutaneously may be administered.

Deficiency in Adolescents:

2.5 to 25 mg orally once every 24 hours. Alternatively, 10 mg IV, IM or subcutaneously may be administered.

Adverse Effect :

Transient flushing sensations and peculiar sensations of taste have been observed following phytonadione injection as well as rare instances of dizziness, rapid and weak pulse, profuse sweating, brief hypotension, dyspnea, and cyanosis. Bronchospasm, shock, cardiac and/or respiratory arrest may also occur. Pain, swelling, and tenderness at the injection site may occur. Large doses of vitamin K or its analogues may further depress liver function in patients with severe hepatic disease and thereby further decrease the concentration of prothrombin.

Neonates: In infants (particularly premature babies), excessive doses of vitamin K analogs during the first few days of life may cause hyperbilirubinemia; this in turn may result in severe hemolytic anemia, hemoglobinuria, kernicterus, leading to brain damage or even death.

Interaction :

No significant interactions are known other than antagonism of coumarin anticoagulants.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDUnlikely to be dialysed. Dose as in normal renal function
HDUnlikely to be dialysed. Dose as in normal renal function
HDF/High fluxDialysed. Dose as in normal renal function
CAV/VVHDUnlikely to be dialysed. Dose as in normal renal function

Hepatic Dose :

No dose adjustment recommended.
03/20/2024 13:18:56 Vitamin K
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0